Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)

Fach | Thilo | D. DeMets | B. Fagerberg | B. Lüderitz | Jeffrey L. Anderson | K. Dickstein | A. Jánosi | G. Thorgeirsson | H. Kennedy | M. Gheorghiade | J. Hradec | J. Feyzi | S. Gottlieb | B. Hamer | B. Lernfelt | K. Labresh | D. Murdoch | K. Wrabec | S. Lehto | P. Deedwania | P. Erne | J. Cornel | R. Dietz | D. Mann | M. Frenneaux | P. Bernink | P. Fenster | P. Batin | J. Ghali | U. Elkayam | P. Svítil | M. Higginbotham | H. Völler | J. Herlitz | F. Waagstein | C. Werter | R. Steingart | J. Hoorntje | H. Wedel | P. Alagona | A. Liem | J. Kjekshus | A. Struthers | P. Dunselman | S. Ball | S. Goldstein | G. Heyndrickx | J. Vandenbossche | K. Chatterjee | M. Sveinsdóttir | B. Andersson | R. Karlsberg | J. Rybka | K. Egstrup | P. Mohacsi | J. Viersma | Hepp | G. Uhl | Z. Kornacewicz-Jach | D. Andresen | K. Berkin | L. Gullestad | U. Thadani | R. Dibianco | J. Aldershvile | J. Bucx | R. Weiss | K. Phadke | T. Omland | A. Gradman | A. Hjalmarson | J. Wikstrand | G. Westergren | M. Thimell | D. E. Allaf | J. Vítovec | M. Halinen | K. Neuhaus | J. Kuch | P. Rickenbacher | G. Vandenhoven | I. Novàkovà | S. Danker | M. Lundström | W. Meyer-Sabellek | I. Balla | B. Dorhout | A. Hildebrandt | I. Szczurko | C. Larsson | E. Bucher | E. Scott | D. Dwyer | D. Julian | P. Karpati | W. Motz | O. Samuelsson | C. Berthe | J. Boutefeu | G. Boxho | P. Decroly | J. P. Derbaudrenghien | J. Pirlet | P. D. Henry | L. Missault | M. Nannan | P. Timmermans | J. Vachiéry | W. V. Mieghem | K. Dvořák | M. Herold | A. Kana | P. Petr | J. Smid | J. Toman | E. Agner | O. Amtorp | P. Eliasen | C. Gøtzsche | P. Hildebrandt | A. Johannesen | P. Kaiser-Nielsen | H. Nielsen | P. Nielsen | F. Pedersen | J. Nielsen | K. Skagen | T. Honkanen | E. Hussi | J. Juvonen | H. Jääskeläinen | J. Rinne | T. Salonen | H. Berwing | Bethge | Beythien | Bischoff | Bundschu | Daniel | Darius | Delius | Drude | Dingerkus | Dück | Eichler | A. Förster | Girth | Goss | Hahn | Hambrecht | G. Hauf | Heinemann | Janka | Klocke | Konz | B. Krosse | Kühlkamp | Lewek | Löbe | Maier | Melchior | Müller | Mäurer | Nast | Neuhaus | Obst | Odemar | K. Olshausen | Pomykaj | K. Schmailzl | Schrader | Schröder | P. Schwimmbeck | M. Sigmund | Simon | Strasser | Vöhringer | Weibrodt | Wirtz | I. Czuriga | M. Hetey | A. Katona | M. Lengyel | A. Nyárádi | A. Rednik | K. Sándori | P. Szabó | J. Tarján | J. Tenczer | S. Timar | P. Vályi | G. Veress | K. Zámolyi | B. Öze | G. Thorgeirsson | G. Thorgeirsson | A. Bredero | R. Breedveld | P. Breuls | P. D. Milliano | N. Holwerda | J. Hoogsteen | J. Kragten | G. Linssen | H. R. Michels | A. R. Misier | H. Schaafsma | P. Sijbring | R. Taverne | L. H. Kempen | R. Stralen | P. V. Veldhuisen | M. Veerhoek | J. Wesdorp | A. Willems | A. Withagen | P. A. Zwart | R. Bjørnerheim | M. Dahle | G. Frøland | T. Gundersen | K. Hofsoy | T. Hole | T. Johansen | J. Mannsverk | P. Nesje | C. Sjödin | P. Smith | H. Tjonndal | O. Vikesdal | K. Waagé | Adamus | K. Jaworska | P. Kołodziej | M. Krzeminska-Pakula | J. Piotrowski | W. Piwowarska | A. Stogowski | J. Wodniecki | P. Ahlström | S. Ekdahl | L. Hemmingson | L. Holmberg | H. Widgren | K. Ångman | R. Polikar | H. Schläpfer | T. Callaghan | J. Forfar | R. Greenbaum | M. Maltz | G. Reynolds | J. Stephens | J. Swan | G. Tildesley | A. Abbasi | J. Alderman | M. Alipour | Z. Ansari | M. Ashraf | B. Beanblossom | S. Bennett | D. Benvenuti | M. Berk | R. Bhalla | S. Bilazarian | K. Browne | C. MBuchter | R. Carlson | C. Carlson | K. Danisa | I. Dauber | M. Dewood | G. Dennish | D. M. Denny | P. Diller | M. Dunlap | K. Dowd | A. Edmiston | M. E. Shahawy | J. Farnham | S. Friedman | T. Heywood | J. Galichia | M. Geller | T. Giles | R. Gillespe | G. Goldberg | M. C. Goldberg | D. Goldscher | G. P. Gooden | M. Goodman | L. Goodman | J. Gorwit | D. Grech | T. Hack | J. Hall | M. Hattenhauer | S. Hutchins | M. Imburgia | B. Iteld | B. Jackson | S. Jafri | W. Jauch | S. Jennison | B. Kahn | W. Kao | K. Kaplan | J. Kennedy | L. Kirkegaard | D. Kraus | L. Lalonde | M. Lesser | R. Levites | M. Lévy | R. K. Lewis | I. Loh | H. Madyoon | F. Maislos | G. L. Maurice | A. Nisar | W. Old | J. Pappas | S. Promisloff | A. Rashkow | B. Reeves | J. Rosen | M. Rotman | T. Saleem | S. Savran | R. Shah | Y. Shalev | J. Shanes | M. O'Shaughnessy | B. Silverman | L. Swenson | K. Syed | R. Thorsen | M. Tonkon | R. Touchon | K. Vaska | S. Wagner | C. Weaver | W. Wickemeyer | H. Willens | J. Wilson | R. Wright | L. Yellen | J. Šmid | J. Vachiéry | I. Novakova | P. Dunselman | Peter H.J.M. Dunselman | Z. Kornacewicz‐Jach | H. Michels | W. Mieghem | Å. Hjalmarson | M. A. Dewood | M. Goldberg | Janka | R. Shah | S. Danker

[1]  H. Kennedy,et al.  Metoprolol CR/XL in patients with heart failure: A pilot study examining the tolerability, safety, and effect on left ventricular ejection fraction. , 1999, American heart journal.

[2]  Thomas D. Giles,et al.  Consensus recommendations for the management of chronic heart failure: Introduction , 1999 .

[3]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[4]  B. Andersson.  3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial , 1998, The Lancet.

[5]  P. Lauriola,et al.  Avoidable deaths from vehicle accidents in Modena, Italy , 1998, The Lancet.

[6]  K. Swedberg,et al.  Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Göteborg Metoprolol Trial). , 1997, The American journal of cardiology.

[7]  I. Kobrin,et al.  Safety of mibefradil, a new once-a-day, selective T-type calcium channel antagonist. , 1997, The American journal of cardiology.

[8]  P. Heidenreich,et al.  Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. , 1997, Journal of the American College of Cardiology.

[9]  R. Doughty,et al.  Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. , 1997, European heart journal.

[10]  Australia..  Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease , 1997, The Lancet.

[11]  J. Herlitz.  Rationale, design, and organisation of the metoprolol CR/XL randomized trial in heart failure (MERIT-HF) , 1997 .

[12]  K. Swedberg,et al.  Beta-blocking agents in heart failure. Should they be used and how? , 1996, European heart journal.

[13]  A. Hall,et al.  Mode of death in chronic heart failure. A request and proposition for more accurate classification. , 1996, European heart journal.

[14]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[15]  S. Yusuf,et al.  Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure , 1995 .

[16]  S. Yusuf,et al.  Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. , 1995, JAMA.

[17]  L. Wilkins.  A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. , 1994, Circulation.

[18]  K. Swedberg,et al.  Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy , 1993, The Lancet.

[19]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[20]  M. Kendall,et al.  The role of beta receptor blockade in preventing sudden death. , 1992, European heart journal.

[21]  E. Sonnenblick,et al.  Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. , 1992, European heart journal.

[22]  J. Tuomilehto,et al.  Primary prevention of sudden cardiovascular death in hypertensive patients. Mortality results from the MAPHY Study. , 1991, American journal of hypertension.

[23]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[24]  R. Byington,et al.  Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. , 1986, Circulation.

[25]  T. Gundersen.  Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction. , 1983, British heart journal.

[26]  K. Swedberg,et al.  PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE , 1979, The Lancet.

[27]  E. Varnauskas,et al.  Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. , 1975, British heart journal.